Bioventus Inc. (BVS) [Rocket]

In millions, except per share items	Jul-01-23	Apr-01-23	Dec-31-22	Oct-01-22	Jul-02-22	Apr-02-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	8-K
Assets
Current assets:
Cash and cash equivalents	29	47	32	34	41	27	44	22,587
Accounts receivable, net	120	119	137	132	143	119	125	12,398
Inventory	96	88	85	77	69	65	62	16,119
Prepaid and other current assets	15	17	19	28	24	29	27	1,044
Total current assets	261	309	273	271	277	245	263	52,147
Property and equipment, net	42	37	28	27	25		23
Goodwill	7	7	14	15	143	148	148	108,235
Intangible assets, net	505	516	1,039	1,056	667	681	695	20,174
Operating lease assets	15	16	17	16	18	19	17
Investment and other assets	7	3	3	13	78	29	29
Total assets	837	887	1,373	1,398	1,209	1,197	1,226	192,120

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	41	33	38	19	26	23	17	7,630
Accrued liabilities	122	116	112	117	147	125	131	8,761
Current portion of long-term debt	11	41	33	31	23	20	18	7,699
Other current liabilities	5	4	4	3	4	4	4
Total current liabilities	179	196	304	288	199	172	181	24,578
Long-term debt, less current portion	375	404	385	393	351	348	340
Deferred income taxes		0	154	159	99	116	134	73
Contingent consideration	18	18	85	82	17	17	16
Other long-term liabilities	32	29	25	24	23	23	22	846
Total liabilities	604	647	1,032	1,019	689	675	692	63,022

Commitments and contingencies (Note 11)
Stockholders’ Equity
Common stock, value
Additional paid-in capital	491	492	482	478	474	468	465	190,190
Accumulated deficit	-308	-304	-165	-133	-25	-18	-7	-61,093
Accumulated other comprehensive income (loss)	1	0	0	-1	-1	0	0
Total stockholders’ equity attributable to Bioventus Inc.	183	189	317	343	448	450	459	129,098
Noncontrolling interest	50	52	24	36	72	72	75
Total stockholders’ equity	233	240	340	379	520	522	534
Total liabilities and stockholders’ equity	837	887	1,373	1,398	1,209	1,197	1,226	192,120